Actionable news
0
All posts from Actionable news
Actionable news in FLXN: FLEXION THERAPEUTICS Inc,

Flexion Therapeutics releases salary data. CEO sees compensation rise 13%

Flexion Therapeutics just filed its annual proxy statement, which details the salary information of its key executives. In 2015, the company's CEO made 3,240,339.

The table is included below:

Name and Principal Position

Year Salary
($)
Bonus (1)
($)
Option
Awards (2)
($)
All Other
Compensation
($)
Total
($)

Michael D. Clayman, M.D.

President, CEO and Co-Founder

2015 480,000 216,000 2,520,100 24,239 (3) 3,240,339
2014 450,204 225,102 2,149,718 32,357 (3) 2,857,381

Neil Bodick, M.D., Ph.D.

CMO and Co-Founder

2015 368,000 132,480 1,030,950 27,678 (4) 1,559,108
2014 337,653 135,061 859,887 13,418 (4) 1,346,019

Frederick W. Driscoll

CFO

2015 324,000 107,730 916,400 24,249 (5) 1,372,379
2014 305,548 106,942 429,944 22,706 (5) 865,140

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Flexion Therapeutics makes a similar move, sign up!

Other recent filings from the company include the following:

Flexion: Form, Schedule Or Registration Statement No Filing Party: Date Filed: - April 26, 2016
Flexion Therapeutics Announces Presentation Of Results FROM PIVOTAL PHASE 2B AND PHASE 3 CLINICAL TRIALS FOR ZILRETTA AT OSTEOARTHRITIS RESEARCH SOCIETY INTERNATIONAL (OARSI) 2016 WORLD CONGRESS - April 4, 2016